Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

novartis_outside_1

Novartis unveils strong Phase 3 efficacy for one-time therapy Zolgensma in paediatric spinal muscular atrophy

October 1, 2020 Research and Development Novartis, Zolgensma, spinal muscular atrophy

Novartis has lifted the curtain on new Phase 3 data from an ongoing trial of 33 participants on the efficacy …
News
shutterstock_38078521

Enlivex’s Allocetra improves COVID-19 recovery times, early data show

October 1, 2020 Research and Development Allocetra, Enlivex

Israeli immunotherapy firm Enlivex Therapeutics has released tentatively positive data for its therapy Allocetra as a treatment for patients with …
News
800px-healthcare_workers_wearing_ppe_03

Coronavirus transmission in India driven by superspreaders

October 1, 2020 Research and Development

India’s largest contract tracing study has found that the virus has been transmitted through ‘super spreaders.’ The study was conducted …
News
backlit_keyboard

Russia is spreading lies about COVID-19 vaccines, alleges UK Chief of Defence Staff

October 1, 2020 Research and Development Hackers, Russia, Russians, coronavirus vaccine

Russia is sowing disinformation about COVID-19 vaccines to undermine inoculation efforts in Western aligned countries, according to a top UK …
News
800px-library_of_congress_open_house_2182091

High US drug prices driven by profits, House Oversight Committee report finds

October 1, 2020 Research and Development

The rising cost of US drugs are primarily driven by the pursuit of profit by pharmaceutical companies, according to an …
News
nice_new_london_office_internal_3_web

NICE gives go-ahead for Sandoz’s Rizmoic to treat opioid-induced constipation

September 30, 2020 Research and Development, Sales and Marketing NHS, NICE, Rizmoic, Sandoz, UK

The National Institute for Health and Care Excellence (NICE) has recommended Sandoz’s Rizmoic (naldemedine) for the treatment of opioid-induced constipation …
News
bel-n-garijo-large

Company veteran Belén Garijo named as Merck KGaA’s first-ever female CEO

September 30, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck KGaA

German pharma firm Merck KGaA has taken the decision to appoint its first female Chief Executive Officer in its 352-year …
News
800px-a_tamiflu_oseltamivir_capsule

Judge allows $1.5 billion Tamiflu stockpiling lawsuit against Roche to go ahead

September 30, 2020 Research and Development Roche, Tamiflu

A Maryland federal judge denied Roche’s motion to throw out a lawsuit that alleges the company defrauded the US and …
News
amoeba

Brain-eating amoeba in Texas water supply kills six-year-old

September 30, 2020 Research and Development amoeba, brain eating ameoba

Officials in Texas have said it could take two to three months to disinfect the water supply in Lake Jackson …
News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

September 30, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten

The coronavirus news this week focuses on the development of treatments to alleviate symptoms of the virus, as Australian biotech …
News
pharmafocus_october_2020

The October 2020 issue of Pharmafocus is available to read free online now!

September 29, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020, October 2020, Pharmafocus, digital edition, pharma

The latest monthly edition of Pharmafocus is available to read for free online now! As the US sails past the …
News
european_commission_web

Jyseleca secures European approval in rheumatoid arthritis

September 28, 2020 Research and Development, Sales and Marketing Europe, Jyseleca, arthritis, pharma

The European Commission has awarded approval to Gilead and Galpagos for their oral JAK inhibitor Jyseleca (filgotinib) as a treatment …
News
nasal-spray-drawing

Novel prophylactic nasal spray reduced COVID-19 replication by 96% in animal studies

September 28, 2020 Research and Development, Sales and Marketing COVID-19, Ena Respiratory, Nasal Spray

Australian biotech Ena Respiratory has revealed new data demonstrating that its novel nasal spray almost halted replication of the SARS-CoV-2 …
News

Novartis’ Zolgensma hits regulatory hurdle after FDA asks to review another study

September 24, 2020 Research and Development FDA

The FDA has requested an additional study in older children being treated with Novartis’ Zolgensma in the review process for …
News
fda_21_4

FDA grants Emergency Use Authorization for first antibody point-of-care COVID-19 test

September 24, 2020 Research and Development

The FDA has issued an Emergency Use Authorization (EUA) for the first antibody (serology) point-of-care test for coronavirus.  This is …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026